by Annie De Groot | Dec 22, 2020 | Thinking Out Loud -Blog
2020 Hindsight and Paying it Forward It has been an upside down year during which time we’ve learned a lot about our ability to work from home and still carry out global collaborations. EpiVax embraces the positive changes that have occurred and celebrates the...
by Annie De Groot | Dec 15, 2020 | Featured, News
PROVIDENCE, RI, December 15, 2020 /PRNewswire/ — EpiVax, Inc. reports a record-breaking year for the “ISPRI” immunogenicity screening toolkit. More pharmaceutical and biotechnology companies signed new and continuing licenses for access to the toolkit in 2020...
by Annie De Groot | Nov 16, 2020 | Events
Dr. Anne De Groot will be participating in the 8th annual AIS “Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases” Dr. De Groot will be speaking on Tuesday Nov 24, during the Track From Preclinical to Drug Approval at...
by Annie De Groot | Oct 27, 2020 | Events, Featured
EpiVax is proud to have three of our Director and Senior level scientists representing our work at the 2020 AAPS PharmSci 360 Meetings. There are several opportunities to catch up with them over the next two weeks including the following rapid fire talks: Brian...
by Annie De Groot | Oct 27, 2020 | Thinking Out Loud -Blog
The What If Machine, as applied to Immunogenicity Well Hello Again! Our PANDA program is back in the news. Having just completed validation studies on Salmon Calcitonin and Teriparatide, we’re back in the business of predicting the future with the What If...
